Jeffrey Geske's guest appearances

Jeffrey Geske

Cardionerds: A Cardiology Podcast

OwlTail

CardioNerds co-founder Dr. Amit Goyal and episode leads Dr. Jaya Kanduri (FIT Ambassador from Cornell University) and Dr. Jenna Skowronski (FIT Ambassador from UPMC) discuss Complications of acute myocardial infarction with expert faculty Dr. Jeffrey Geske. They discuss various complications of acute MI such as cardiogenic shock, bradyarrythmias, left ventricular outflow tract obstruction, ruptures (papillary muscle rupture, VSD, free wall rupture), and more. Show notes were drafted by Dr. Jaya Kanduri. Audio editing by CardioNerds Academy Intern, student doctor Tina Reddy. The CardioNerds Beyond the Boards Series was inspired by the Mayo Clinic Cardiovascular Board Review Course and designed in collaboration with the course directors Dr. Amy Pollak, Dr. Jeffrey Geske, and Dr. Michael Cullen. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Beyond the Boards SeriesCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls and Quotes – Complications of Acute Myocardial Infarction  Sinus tachycardia is a “harbinger of doom”! The triad for RV infarction includes hypotension, elevated JVP, and clear lungs. These patients are preload dependent and may need fluid resuscitation despite having an elevated JVP. Bradyarrythmias in inferior MIs are frequently vagally mediated. The focus should be on medical management before committing to a temporary transvenous pacemaker, such as reperfusion, maintaining RV preload and inotropy, avoiding hypoxia, and considering RV-specific mechanical circulator support (MCS). Worsening hypotension with inotropic agents (e.g., dobutamine, epinephrine, dopamine, norepinephrine) after a large anterior-apical MI should raise suspicion for dynamic left ventricular outflow tract obstruction due to compensatory hyperdynamic basal segments. The myocardium after a late presentation MI is as “mushy as mashed potatoes”! Need to look out for papillary muscle rupture, VSD, and free wall rupture as potential complications. Papillary muscle rupture can occur with non-transmural infarcts, and often presents with flash pulmonary edema. VSDs will have a harsh systolic murmur and are less likely to present with pulmonary congestion. Free wall rupture can present as a PEA arrest. All of these complications require urgent confirmation on imaging and early involvement of surgical teams.  Notes – Complications of Acute Myocardial Infarction How should we approach cardiogenic shock (CS) in acute myocardial infarction (AMI)?  Only 10% of AMI patients present with CS, but CS accounts for up to 70-80% of mortality associated with AMI, usually due to extensive LV infarction with ensuing pump failure. Physical exam  Sinus tachycardia is considered a “harbinger of doom”, when the body compensates for low cardiac output by ramping up the heart rate   The presence of sinus tachycardia and low pulse and/or blood pressure in a patient with a large anterior MI should raise suspicion for cardiogenic shock   Be wary of giving IV beta blockers in this situation as negative inotropes can precipitate cardiogenic shock (Commit Trial)   When interpreting a patient’s blood pressure in the acute setting, it is helpful to know their baseline blood pressure and if they have a significant history of hypertension.   Patients &lt;75 years of age with CS have improved survival at 6 months and at 1 year with early revascularization (SHOCK trial) Mechanical circulatory support  Intra-aortic balloon pump (IABP)  No mortality benefit with IABP use in CS at 30 days and at 1 year (IABP-SHOCK II trial)   ACC/AHA guidelines give IABP a class IIa recommendation for medically refractory AMI-CS in the USA, whereas the ESC guidelines give it a class III recommendation.     Percutaneous left ventricular assist device (Impella)  No difference in mortality between IABP or Impella use after 30 days or 6 months (IMPRESS trial)   However, observational data like the Detroit &amp; VAD registries show improvement in survival with Impella use in AMI-CS with the cost of excess complications (vascular injury, bleeding, etc)   Upcoming trials (DanGer Shock and Recover IV) will hopefully have more promising data supporting the use of Impella in AMI-CS     In the setting of discrepant guidelines, the decision for MCS should be multidisciplinary and based on clinical expertise.     For more on AMI-CS, enjoy CardioNerds #223. CCC: Approach to Acute Myocardial Infarction Cardiogenic Shock with Dr. Venu Menon  How does RV infarction present?  Physical exam  RV infarct triad: hypotension, elevated JVP, clear lungs   Hypotension precipitated by nitroglycerin administration highlights the preload dependent state of an infarcted RV   GI symptoms (nausea and emesis) are common   Patients may actually need fluids despite an elevated JVP because of an underfilled left ventricle   EKG  Consider a right sided leads (ST elevation in V1 and V4R are the most sensitive EKG markers of RV injury), but this should not delay emergent coronary angiography +/- PCI if suspicion for AMI is high   Rhythm  AV synchrony plays an important role in RV infarct given the dependence on preload   If a patient loses AV synchrony due to heart block or atrial fibrillation, they can become more unstable due to a further drop in RV preload and overall cardiac output   However, bradyarrythmias in inferior MIs are frequently vagally mediated, and therefore temporary   Strategy for management of an inferior MI with RV infarct should be to optimize all other aspects hemodynamically before placing a temporary transvenous pacemaker (risk of RV perforation)  Prompt reperfusion   Maintain RV preload   Inotropes   Avoid hypoxia (potent pulmonary vasoconstriction, can increase RV afterload)   MCS providing RV support (Protek-Duo, RP Impella, VA-ECMO)     For more on RV-predominant cardiogenic shock, enjoy CardioNerds #239. CCC: Approach to RV Predominant Cardiogenic Shock with Dr. Ryan Tedford  How does LVOT obstruction in a large anterior MI present?  Hypotension with dobutamine or norepinephrine in a patient with an anterior MI and apical infarct, should raise suspicion for dynamic left ventricular outflow tract obstruction due to compensatory hyperdynamic basal walls Echocardiography is invaluable for diagnosis! Management  Prompt reperfusion   IV fluids (preload dependent)   Beta blockers (eg: esmolol quick on, quick off)   Phenylephrine (can improve BP by increasing afterload)   Avoid positive inotropes (e.g., norepinephrine, epinephrine, dopamine, dobutamine, milrinone)   Avoid IABP    What are the different types of ruptures which may complicate a late-presentating MI?  Papillary muscle rupture  Posteromedial papillary more likely to be affected due to single coronary blood supply   Papillary muscles are subendocardial so rupture can occur with non-transmural infarcts   Presents with acute dyspnea from flash pulmonary edema and hypotension from drop in cardiac output   Exam with new systolic murmur which may not be audible due to rapid equalization of pressures. For the same reason, Doppler may also underestimate the degree of MR.   V wave from mitral regurgitation   Ventricular septal rupture  Risk factors: advanced age, female sex, first MI with lack of coronary collaterals   Presents with hypotension, chest discomfort, dyspnea   Exam with harsh systolic murmur with palpable thrill; pulmonary congestion is unusual unusual   V wave from increased flow through the pulmonary circuit (but not high enough to cause flash pulmonary edema)   Step up in RV saturation during right heart catheterization   Inferobasal VSD with RCA infarcts (near the valves and conduction tissue and with more serpentine lesions, leading to worse outcomes)   Apical VSD with LAD infarcts (can miss on TTE)   Free wall rupture  Risk factors: advanced age, female sex, first MI with lack of coronary collaterals   Partial rupture may present as a vagal event that heralds the initial tear; TTE with new pericardial effusion should raise suspicion of an incomplete rupture   Full rupture can present as PEA arrest with abysmally low survival   May partially heal as a pseudo-aneurysm    How do we manage rupture complications?  For any of the three rupture scenarios (VSR, papillary muscle rupture, or free wall rupture), time is of the essence to confirm the site of rupture and to get the surgical team involved Can have abrupt, unexpected, unpredictable progression so need to bring in surgical expertise early Papillary muscle rupture will need mitral valve replacement For VSR closure, can pursue surgical versus percutaneous options depending on anatomical features of the lesion and patient characteristics  Intervention is more challenging in inferobasal VSRs with higher operative mortality, but also less amenable to percutaneous closure (less likely to have appropriate rims for closure)   If poor operative candidacy, more likely to opt for percutaneous options   If size of defect large, would more likely lean towards surgery   Can consider bridging with MCS if patient in CS (eg: IABP, Impella) as long as this will not delay the surgical intervention  References  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial. The Lancet. 2005;366(9497):1622-1632. doi:10.1016/s0140-6736(05)67661-1. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)67661-1/fulltext Dzavik V. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: A report from the Shock Trial Registry. European Heart Journal. 2003;24(9):828-837. doi:10.1016/s0195-668x(02)00844-8. https://www.nejm.org/doi/full/10.1056/nejm199908263410901 Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with Cardiogenic shock. New England Journal of Medicine. 2012;367(14):1287-1296. doi:10.1056/nejmoa1208410. https://www.nejm.org/doi/full/10.1056/nejmoa1208410 Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Journal of the American College of Cardiology. 2017;69(3):278-287. doi:10.1016/j.jacc.2016.10.022. https://www.jacc.org/doi/epdf/10.1016/j.jacc.2016.10.022 O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425. https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742cf6 Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. https://pubmed.ncbi.nlm.nih.gov/25173339/ Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: A scientific statement from the American Heart Association. Circulation. 2021;144(2). doi:10.1161/cir.0000000000000985. https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000985 

<a href="https://twitter.com/CardioNerds" rel="noreferrer noopener nofollow" target="_blank">CardioNerds</a> co-founder <a href="https://twitter.com/AmitGoyalMD" rel="noreferrer noopener nofollow" target="_blank">Dr. Amit Goyal </a>and episode leads <a href="https://twitter.com/jaya_kanduri" rel="noreferrer noopener nofollow" target="_blank">Dr. Jaya Kanduri </a>(FIT <a href="https://www.cardionerds.com/honor-roll-ambassadors/" rel="noreferrer noopener nofollow" target="_blank">Ambassador</a> from Cornell University) and <a href="https://twitter.com/jennaskowronski" rel="noreferrer noopener nofollow" target="_blank">Dr. Jenna Skowronski</a> (FIT Ambassador from UPMC) discuss Complications of acute myocardial infarction with expert faculty Dr. Jeffrey Geske. They discuss various complications of acute MI such as cardiogenic shock, bradyarrythmias, left ventricular outflow tract obstruction, ruptures (papillary muscle rupture, VSD, free wall rupture), and more. Show notes were drafted by Dr. Jaya Kanduri. Audio editing by <a href="https://www.cardionerds.com/academy/" rel="nofollow" target="_blank">CardioNerds Academy Intern</a>, student doctor <a href="https://twitter.com/TinaKReddy" rel="nofollow" target="_blank">Tina Reddy</a>. The CardioNerds Beyond the Boards Series was inspired by the <a href="https://cveducation.mayo.edu/store/cardiovascular-board-review-for-initial-certification-and-recertification" rel="noreferrer noopener nofollow" target="_blank">Mayo Clinic Cardiovascular Board Review Course</a> and designed in collaboration with the course directors <a href="https://twitter.com/DrAmyPollak" rel="noreferrer noopener nofollow" target="_blank">Dr. Amy Pollak</a>, <a href="https://twitter.com/jeffreygeske" rel="noreferrer noopener nofollow" target="_blank">Dr. Jeffrey Geske</a>, and <a href="https://twitter.com/mwcullen" rel="noreferrer noopener nofollow" target="_blank">Dr. Michael Cullen</a>. <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061404" rel="noreferrer noopener nofollow" target="_blank">Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values.</a> <a href="https://www.uscjournal.com/articles/case-primary-cardiac-b-cell-lymphoma-diagnosed-cardiac-mri" rel="nofollow" target="_blank">US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here.</a> <a href="https://www.cardionerds.com/beyond-boards/" rel="noreferrer noopener nofollow" target="_blank">CardioNerds Beyond the Boards Series </a><a href="https://www.cardionerds.com/episodes/" rel="noreferrer noopener nofollow" target="_blank">CardioNerds Episode Page</a> <a href="https://www.cardionerds.com/academy/" rel="noreferrer noopener nofollow" target="_blank">CardioNerds Academy</a> <a href="https://www.cardionerds.com/honor-roll-ambassadors/" rel="noreferrer noopener nofollow" target="_blank">Cardionerds Healy Honor Roll</a> <a href="https://www.cardionerds.com/cardsjc/" rel="noreferrer noopener nofollow" target="_blank">CardioNerds Journal Club </a><a href="http://eepurl.com/hazGYL" rel="noreferrer noopener nofollow" target="_blank">Subscribe to The Heartbeat Newsletter!</a> <a href="https://teespring.com/cardionerds?pid=658&amp;cid=102908" rel="noreferrer noopener nofollow" target="_blank">Check out CardioNerds SWAG!</a> <a href="https://www.patreon.com/cardionerds" rel="noreferrer noopener nofollow" target="_blank">Become a CardioNerds Patron!</a> <h3>Pearls and Quotes – Complications of Acute Myocardial Infarction</h3> <ol> <li>Sinus tachycardia is a “harbinger of doom”!</li> <li>The triad for RV infarction includes hypotension, elevated JVP, and clear lungs. These patients are preload dependent and may need fluid resuscitation despite having an elevated JVP.</li> <li>Bradyarrythmias in inferior MIs are frequently vagally mediated. The focus should be on medical management before committing to a temporary transvenous pacemaker, such as reperfusion, maintaining RV preload and inotropy, avoiding hypoxia, and considering RV-specific mechanical circulator support (MCS).</li> <li>Worsening hypotension with inotropic agents (e.g., dobutamine, epinephrine, dopamine, norepinephrine) after a large anterior-apical MI should raise suspicion for dynamic left ventricular outflow tract obstruction due to compensatory hyperdynamic basal segments.</li> <li>The myocardium after a late presentation MI is as “mushy as mashed potatoes”! Need to look out for papillary muscle rupture, VSD, and free wall rupture as potential complications. Papillary muscle rupture can occur with non-transmural infarcts, and often presents with flash pulmonary edema. VSDs will have a harsh systolic murmur and are less likely to present with pulmonary congestion. Free wall rupture can present as a PEA arrest. All of these complications require urgent confirmation on imaging and early involvement of surgical teams.</li> </ol> <h3>Notes – Complications of Acute Myocardial Infarction</h3> How should we approach cardiogenic shock (CS) in acute myocardial infarction (AMI)? <ul> <li>Only 10% of AMI patients present with CS, but CS accounts for up to 70-80% of mortality associated with AMI, usually due to extensive LV infarction with ensuing pump failure.</li> <li>Physical exam <ul> <li>Sinus tachycardia is considered a “harbinger of doom”, when the body compensates for low cardiac output by ramping up the heart rate</li> </ul> <ul> <li>The presence of sinus tachycardia and low pulse and/or blood pressure in a patient with a large anterior MI should raise suspicion for cardiogenic shock</li> </ul> <ul> <li>Be wary of giving IV beta blockers in this situation as negative inotropes can precipitate cardiogenic shock (Commit Trial)</li> </ul> <ul> <li>When interpreting a patient’s blood pressure in the acute setting, it is helpful to know their baseline blood pressure and if they have a significant history of hypertension.</li> </ul> </li> <li>Patients &lt;75 years of age with CS have improved survival at 6 months and at 1 year with early revascularization (SHOCK trial)</li> <li>Mechanical circulatory support <ul> <li>Intra-aortic balloon pump (IABP) <ul> <li>No mortality benefit with IABP use in CS at 30 days and at 1 year (IABP-SHOCK II trial)</li> </ul> <ul> <li>ACC/AHA guidelines give IABP a class IIa recommendation for medically refractory AMI-CS in the USA, whereas the ESC guidelines give it a class III recommendation.</li> </ul> </li> </ul> <ul> <li>Percutaneous left ventricular assist device (Impella) <ul> <li>No difference in mortality between IABP or Impella use after 30 days or 6 months (IMPRESS trial)</li> </ul> <ul> <li>However, observational data like the Detroit &amp; VAD registries show improvement in survival with Impella use in AMI-CS with the cost of excess complications (vascular injury, bleeding, etc)</li> </ul> <ul> <li>Upcoming trials (DanGer Shock and Recover IV) will hopefully have more promising data supporting the use of Impella in AMI-CS</li> </ul> </li> </ul> <ul> <li>In the setting of discrepant guidelines, the decision for MCS should be multidisciplinary and based on clinical expertise.  </li> </ul> </li> <li>For more on AMI-CS, enjoy <a href="https://www.cardionerds.com/223-ccc-approach-to-acute-myocardial-infarction-cardiogenic-shock-with-dr-venu-menon/" rel="nofollow" target="_blank">CardioNerds #223. CCC: Approach to Acute Myocardial Infarction Cardiogenic Shock with Dr. Venu Menon</a></li> </ul> How does RV infarction present? <ul> <li>Physical exam <ul> <li>RV infarct triad: hypotension, elevated JVP, clear lungs</li> </ul> <ul> <li>Hypotension precipitated by nitroglycerin administration highlights the preload dependent state of an infarcted RV</li> </ul> <ul> <li>GI symptoms (nausea and emesis) are common</li> </ul> <ul> <li>Patients may actually need fluids despite an elevated JVP because of an underfilled left ventricle</li> </ul> </li> <li>EKG <ul> <li>Consider a right sided leads (ST elevation in V1 and V4R are the most sensitive EKG markers of RV injury), but this should not delay emergent coronary angiography +/- PCI if suspicion for AMI is high</li> </ul> </li> <li>Rhythm <ul> <li>AV synchrony plays an important role in RV infarct given the dependence on preload</li> </ul> <ul> <li>If a patient loses AV synchrony due to heart block or atrial fibrillation, they can become more unstable due to a further drop in RV preload and overall cardiac output</li> </ul> <ul> <li>However, bradyarrythmias in inferior MIs are frequently vagally mediated, and therefore temporary</li> </ul> <ul> <li>Strategy for management of an inferior MI with RV infarct should be to optimize all other aspects hemodynamically before placing a temporary transvenous pacemaker (risk of RV perforation) <ul> <li>Prompt reperfusion</li> </ul> <ul> <li>Maintain RV preload</li> </ul> <ul> <li>Inotropes</li> </ul> <ul> <li>Avoid hypoxia (potent pulmonary vasoconstriction, can increase RV afterload)</li> </ul> <ul> <li>MCS providing RV support (Protek-Duo, RP Impella, VA-ECMO)</li> </ul> </li> </ul> </li> <li>For more on RV-predominant cardiogenic shock, enjoy <a href="https://www.cardionerds.com/239-ccc-approach-to-rv-predominant-cardiogenic-shock-with-dr-ryan-tedford/" rel="nofollow" target="_blank">CardioNerds #239. CCC: Approach to RV Predominant Cardiogenic Shock with Dr. Ryan Tedford</a></li> </ul> How does LVOT obstruction in a large anterior MI present? <ul> <li>Hypotension with dobutamine or norepinephrine in a patient with an anterior MI and apical infarct, should raise suspicion for dynamic left ventricular outflow tract obstruction due to compensatory hyperdynamic basal walls</li> <li>Echocardiography is invaluable for diagnosis!</li> <li>Management <ul> <li>Prompt reperfusion</li> </ul> <ul> <li>IV fluids (preload dependent)</li> </ul> <ul> <li>Beta blockers (eg: esmolol quick on, quick off)</li> </ul> <ul> <li>Phenylephrine (can improve BP by increasing afterload)</li> </ul> <ul> <li>Avoid positive inotropes (e.g., norepinephrine, epinephrine, dopamine, dobutamine, milrinone)</li> </ul> <ul> <li>Avoid IABP</li> </ul> </li> </ul> What are the different types of ruptures which may complicate a late-presentating MI? <ul> <li>Papillary muscle rupture <ul> <li>Posteromedial papillary more likely to be affected due to single coronary blood supply</li> </ul> <ul> <li>Papillary muscles are subendocardial so rupture can occur with non-transmural infarcts</li> </ul> <ul> <li>Presents with acute dyspnea from flash pulmonary edema and hypotension from drop in cardiac output</li> </ul> <ul> <li>Exam with new systolic murmur which may not be audible due to rapid equalization of pressures. For the same reason, Doppler may also underestimate the degree of MR.</li> </ul> <ul> <li>V wave from mitral regurgitation</li> </ul> </li> <li>Ventricular septal rupture <ul> <li>Risk factors: advanced age, female sex, first MI with lack of coronary collaterals</li> </ul> <ul> <li>Presents with hypotension, chest discomfort, dyspnea</li> </ul> <ul> <li>Exam with harsh systolic murmur with palpable thrill; pulmonary congestion is unusual unusual</li> </ul> <ul> <li>V wave from increased flow through the pulmonary circuit (but not high enough to cause flash pulmonary edema)</li> </ul> <ul> <li>Step up in RV saturation during right heart catheterization</li> </ul> <ul> <li>Inferobasal VSD with RCA infarcts (near the valves and conduction tissue and with more serpentine lesions, leading to worse outcomes)</li> </ul> <ul> <li>Apical VSD with LAD infarcts (can miss on TTE)</li> </ul> </li> <li>Free wall rupture <ul> <li>Risk factors: advanced age, female sex, first MI with lack of coronary collaterals</li> </ul> <ul> <li>Partial rupture may present as a vagal event that heralds the initial tear; TTE with new pericardial effusion should raise suspicion of an incomplete rupture</li> </ul> <ul> <li>Full rupture can present as PEA arrest with abysmally low survival</li> </ul> <ul> <li>May partially heal as a pseudo-aneurysm</li> </ul> </li> </ul> How do we manage rupture complications? <ul> <li>For any of the three rupture scenarios (VSR, papillary muscle rupture, or free wall rupture), time is of the essence to confirm the site of rupture and to get the surgical team involved</li> <li>Can have abrupt, unexpected, unpredictable progression so need to bring in surgical expertise early</li> <li>Papillary muscle rupture will need mitral valve replacement</li> <li>For VSR closure, can pursue surgical versus percutaneous options depending on anatomical features of the lesion and patient characteristics <ul> <li>Intervention is more challenging in inferobasal VSRs with higher operative mortality, but also less amenable to percutaneous closure (less likely to have appropriate rims for closure)</li> </ul> <ul> <li>If poor operative candidacy, more likely to opt for percutaneous options</li> </ul> <ul> <li>If size of defect large, would more likely lean towards surgery</li> </ul> </li> <li>Can consider bridging with MCS if patient in CS (eg: IABP, Impella) as long as this will not delay the surgical intervention</li> </ul> <h3>References</h3> <ol> <li>Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial. The Lancet. 2005;366(9497):1622-1632. doi:10.1016/s0140-6736(05)67661-1. <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)67661-1/fulltext" rel="nofollow" target="_blank">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)67661-1/fulltext</a></li> <li>Dzavik V. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: A report from the Shock Trial Registry. European Heart Journal. 2003;24(9):828-837. doi:10.1016/s0195-668x(02)00844-8. <a href="https://www.nejm.org/doi/full/10.1056/nejm199908263410901" rel="nofollow" target="_blank">https://www.nejm.org/doi/full/10.1056/nejm199908263410901</a></li> <li>Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with Cardiogenic shock. New England Journal of Medicine. 2012;367(14):1287-1296. doi:10.1056/nejmoa1208410. <a href="https://www.nejm.org/doi/full/10.1056/nejmoa1208410" rel="nofollow" target="_blank">https://www.nejm.org/doi/full/10.1056/nejmoa1208410</a></li> <li>Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Journal of the American College of Cardiology. 2017;69(3):278-287. doi:10.1016/j.jacc.2016.10.022. <a href="https://www.jacc.org/doi/epdf/10.1016/j.jacc.2016.10.022" rel="nofollow" target="_blank">https://www.jacc.org/doi/epdf/10.1016/j.jacc.2016.10.022</a></li> <li>O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425. <a href="https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742cf6" rel="nofollow" target="_blank">https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742cf6</a></li> <li>Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. <a href="https://pubmed.ncbi.nlm.nih.gov/25173339/" rel="nofollow" target="_blank">https://pubmed.ncbi.nlm.nih.gov/25173339/</a></li> <li>Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: A scientific statement from the American Heart Association. Circulation. 2021;144(2). doi:10.1161/cir.0000000000000985. <a href="https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000985" rel="nofollow" target="_blank">https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000985</a></li> </ol>